# FDA 483 - Humacyte Global Inc - April 05, 2024

Source: https://www.globalkeysolutions.net/records/483/humacyte-global-inc/55cd417b-c6b6-4489-9066-3488ed2f9a20

> FDA 483 for Humacyte Global Inc on April 05, 2024. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Humacyte Global Inc
- Inspection Date: 2024-04-05
- Product Type: drugs
- Office Name: Division of Clinical Evidence and Analysis 1 (Clinical Policy and Quality)

## Related Documents

- [EIR - Unknown Date](https://www.globalkeysolutions.net/records/eir/humacyte-global-inc/c8648c0a-930b-40a9-afe7-a142596867c0)
- [EIR - Unknown Date](https://www.globalkeysolutions.net/records/eir/humacyte-global-inc/691ab2d6-40f7-421e-b661-0e8aa010b269)

## Related Officers

- [Laura Ribeiro](https://www.globalkeysolutions.net/people/laura-ribeiro/2c482506-5c1a-4b90-9c90-39115fecbb80)
- [Alifiya H. Ghadiali](https://www.globalkeysolutions.net/people/alifiya-h-ghadiali/b68f818c-b86c-4a52-8fb0-c41317be33ff)
- [Zainab Massango-Horne](https://www.globalkeysolutions.net/people/zainab-massango-horne/b850e60c-9eda-4e63-9d0e-2bb704103699)
- [Lead Biologist](https://www.globalkeysolutions.net/people/jin-sung-hong/c1442e69-a994-4b70-8666-8b77485f63c7)

Company: https://www.globalkeysolutions.net/companies/humacyte-global-inc/74158903-037d-4b32-a3b5-6c90f73f3f1f

Office: https://www.globalkeysolutions.net/offices/division-of-clinical-evidence-and-analysis-1-clinical-policy-and-quality/5f95da17-30bb-423f-b892-5ea041823fbd